galafold 123 mg
truemed ltd, israel - migalastat as hydrochloride - hard capsule - migalastat as hydrochloride 123 mg - galafold is indicated for long-term treatment of adults and adolescents aged 16 years and older with a confirmed diagnosis of fabry disease (α-galactosidase a deficiency) and who have an amenable mutation.
pheburane
truemed ltd, israel - sodium phenylbutyrate - granules - sodium phenylbutyrate 483 mg/g - sodium phenylbutyrate - pheburane is indicated as adjunctive therapy in the chronic management of urea cycle disorders, involving deficiencies of carbamylphosphate synthetase, ornithine transcarbamylase or argininosuccinate synthetase. it is indicated in all patients with neonatal-onset presentation (complete enzyme deficiencies, presenting within the first 28 days of life). it is also indicated in patients with late-onset disease (partial enzyme deficiencies, presenting after the first month of life) who have a history of hyperammonaemic encephalopathy.
granupas
truemed ltd, israel - 4 - aminosalicylic acid - gastro resistant granules - 4 - aminosalicylic acid 4 g/sachet - 4-aminosalicylic acid - granupas is indicated for use as part of an appropriate combination regimen for multi-drug resistant tuberculosis in adults and paediatric patients from 28 days of age and older when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
wakix 18 mg
truemed ltd, israel - pitolisant as hydrochloride - film coated tablets - pitolisant as hydrochloride 17.8 mg - pitolisant - wakix is indicated• in adults for the treatment of narcolepsy with or without cataplexy. • to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa) whose eds has not been satisfactorily treated by, or who have not tolerated, osa primary therapy, such as continuous positive airway pressure (cpap).
wakix 4.5 mg
truemed ltd, israel - pitolisant as hydrochloride - film coated tablets - pitolisant as hydrochloride 4.45 mg - pitolisant - wakix is indicated• in adults for the treatment of narcolepsy with or without cataplexy. • to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa) whose eds has not been satisfactorily treated by, or who have not tolerated, osa primary therapy, such as continuous positive airway pressure (cpap).
nityr ( nitisinone) 10 mg
truemed ltd, israel - nitisinone - tablets - nitisinone 10 mg - nitisinone - treatment of patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht-1) in combination with dietary restriction of tyrosine and phenylalanine.
nityr ( nitisinone) 2 mg
truemed ltd, israel - nitisinone - tablets - nitisinone 2 mg - nitisinone - treatment of patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht-1) in combination with dietary restriction of tyrosine and phenylalanine.
nityr ( nitisinone) 5 mg
truemed ltd, israel - nitisinone - tablets - nitisinone 5 mg - nitisinone - treatment of patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht-1) in combination with dietary restriction of tyrosine and phenylalanine.
exondys 51
truemed ltd, israel - eteplirsen - concentrate for solution for infusion - eteplirsen 50 mg / 1 ml - eteplirsen - exondys 51 is indicated for the treatment of duchenne muscular dystrophy (dmd) in patients who have a confirmed mutation of the dmd gene that is amenable to exon 51 skipping.
alpha d3 0.25 mcg
truemed ltd, israel - alfacalcidol - capsules soft gelatin - alfacalcidol 0.25 mcg - alfacalcidol - alfacalcidol - - renal bone disease (renal osteodystrophy). - hypoparathyroidism. - hyperparathyroidism (with bone disease) - primary and tertiary. - rickets and osteomalacia. - osteoporosis.